Xtant Medical Holdings, Inc. (XTNT)
NYSEAMERICAN: XTNT · Real-Time Price · USD
0.6400
-0.0094 (-1.45%)
Aug 14, 2025, 1:02 PM - Market open
Xtant Medical Holdings Revenue
Xtant Medical Holdings had revenue of $35.41M in the quarter ending June 30, 2025, with 18.26% growth. This brings the company's revenue in the last twelve months to $127.77M, up 15.16% year-over-year. In the year 2024, Xtant Medical Holdings had annual revenue of $117.27M with 28.44% growth.
Revenue (ttm)
$127.77M
Revenue Growth
+15.16%
P/S Ratio
0.70
Revenue / Employee
$550,716
Employees
232
Market Cap
83.40M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 117.27M | 25.96M | 28.44% |
Dec 31, 2023 | 91.30M | 33.33M | 57.50% |
Dec 31, 2022 | 57.97M | 2.71M | 4.90% |
Dec 31, 2021 | 55.26M | 1.93M | 3.61% |
Dec 31, 2020 | 53.34M | -11.35M | -17.54% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
XTNT News
- 2 days ago - Xtant Medical Holdings, Inc. (XTNT) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - Xtant Medical Reports Second Quarter 2025 Financial Results - PRNewsWire
- 7 days ago - Xtant Medical to Attend the CG 45th Annual Growth Conference - PRNewsWire
- 9 days ago - Xtant Medical to Announce Second Quarter 2025 Financial Results on August 12, 2025 - PRNewsWire
- 5 weeks ago - Xtant Medical Announces Definitive Agreements for the Sale of its Coflex® and CoFix® Spinal Implants and All OUS Businesses to Companion Spine - PRNewsWire
- 2 months ago - Xtant Medical Announces the Launch of OsteoFactor Pro™ - PRNewsWire
- 3 months ago - Xtant Medical Holdings, Inc. (XTNT) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Xtant Medical Reports First Quarter 2025 Financial Results - PRNewsWire